Literature DB >> 24250479

Reliability of Disk Diffusion Test Results for the Antimicrobial Susceptibility Testing of Nosocomial Gram-positive Microorganisms: Is E-test Method Better?

Hossein Khalili1, Rasool Soltani, Sorrosh Negahban, Alireza Abdollahi, Keirollah Gholami.   

Abstract

Disk diffusion test is the usual applicable method for assessing the antimicrobial susceptibility pattern in most institutions and hospitals. The aim of this study was to determine the reliability of resistant-reported results of disk diffusion test for 6 routinely used antibiotics against Gram-positive microorganisms of nosocomial origin, using E-test method. Over a 1-year period, clinical specimens (e.g. blood, tracheal secretions, wound secretions, urine, etc.) were obtained from hospitalized patients with defined nosocomial infection and were cultured. Isolated Gram-positive bacteria underwent disk diffusion test for cephalothin, oxacillin, clindamycin, ciprofloxacin, vancomycin, teicoplanin (only for Enterococci), and meropenem antibiotics. E-test method was performed for all isolates resistant or intermediately sensitive to the disks of any mentioned antibiotics. Data showed compatible results of disk diffusion test with the results of E-test method for cephalothin, oxacillin, ciprofloxacin, vancomycin, and teicoplanin. None of ciprofloxacin- and vancomycin-resistant isolates in disk diffusion test showed sensitivity in E-test method. Significant differences between the results of disk diffusion and E-test methods were observed for clindamycin and meropenem against S.aureus (p = 0.01 and 0.04, respectively) and Enterococcus spp (p = 0.03 and 0.02, respectively). In order to increase the reliability of antimicrobial susceptibility results, it is recommended to perform E-test for nosocomial Gram-positive microorganisms that show antibiotic resistance by disk diffusion test and it is more important for clindamycin and meropenem.

Entities:  

Keywords:  Antimicrobial susceptibility test; Disk diffusion; E-test; Gram-positive

Year:  2012        PMID: 24250479      PMCID: PMC3832173     

Source DB:  PubMed          Journal:  Iran J Pharm Res        ISSN: 1726-6882            Impact factor:   1.696


Introduction

The emergence of antimicrobial resistance is a global problem that has been occurred both in the community setting as well as within hospitals (1, 2). It has been estimated that 50-60% of all nosocomial infections in the United States (U.S.) are due to the antibiotic resistant bacteria (3). Gram-positive bacteria-particularly gram-positive cocci like coagulase-negative Staphylococci, Staphylococcus aureus and Enterococcus spp. are extremely important pathogens in the hospital environment (4). Antimicrobial susceptibility testing is an important measure to determine the best antibiotics for the treatment of nosocomial infections. Disk diffusion test is the usual method for this purpose applied in most institutions and hospitals. Considering the value of the results of this test in decision making for antibiotic therapy of infections in hospitalized patients, it is important to know the reliability of its results. In the present study, we evaluated the reliability of resistant-reported results of disk diffusion test and determined the minimum inhibitory concentration (MIC) values for 6 routinely used antibiotics against Gram-positive microorganisms of nosocomial origin, using E-test method.

Experimental

In a prospective Cross-sectional study performed over a 1-year period from March 2009 to March 2010 at Imam Khomeini Hospital (Tehran, Iran), clinical specimens (e.g. blood, tracheal secretions, wound secretions, urine, etc.) were obtained from hospitalized patients with nosocomial infection diagnosed using the Centers for Disease Control and Prevention/National Healthcare Safety Network (CDC/NHSN) definition of health care-associated infections (5) and sent to the hospital’s microbiology lab. All specimens underwent culture and if microbial growth occurred, differential cultures and tests were performed to identify different bacterial strains. Only aerobic Gram-positive strains underwent antimicrobial susceptibility testing using disk diffusion (Kirby-Bauer) test according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (6). After the inoculation of Mueller-Hinton agar culture medium (Merck, Germany) with a direct saline suspension of isolated colonies adjusted to 0.5 McFarland turbidity standard, the antibiotic disks (Padtanteb, Iran) were placed on the agar surface. After 16-18 h of incubation at 35°C, results were interpreted as either sensitive, intermediate, or resistant according to the inhibitory zone diameters around the disks using CLSI breakpoints (7). Antibiotic disks used for the tests included: cephalothin, oxacillin, clindamycin, ciprofloxacin, vancomycin, teicoplanin (only for Enterococci), and meropenem. Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, and Streptococcus pneumoniae ATCC 49619 were used as standard microorganisms for quality control of the tests. To determine the reliability of disk diffusion test and the MIC (minimum inhibitory concentration) of applied antibiotics for bacterial isolates, E-test method was performed for all resistant isolated or intermediately sensitive to disks of any above-mentioned antibiotics using the antibiotic E-test strips (AB biomerieux, Solna, Sweden) according to the manufacturer’s guidelines. After the inoculation of Mueller-Hinton agar culture medium (blood agar for Streptococci) with a direct saline suspension of isolated colonies adjusted to 0.5 McFarland turbidity standard, E-test strips were placed on the agar surface. After 16-20 h of incubation (24 h for vancomycin and teicoplanin) at 35°C, the MIC values, where the edge of the inhibition ellipse intersects the side of the strip, were read. The results were interpreted as either sensitive, intermediate or resistant according to the MIC values using manufacturer’s breakpoints. Statistical analysis SPSS software (version 17) was used for statistical analysis. For comparing the susceptibility results between the resistant microorganisms in disk diffusion and E-test methods, chi-square and fisher exact test were used. P-value less than 0.05 was considered significant.

Results and Discussion

During the study period, a total of 137 isolates of nosocomial Gram-positive bacteria were obtained. Staphylococcus aureus was the most frequently isolated microorganism (n = 77, 56.2%) followed by Enterococcus spp. (n = 30, 21.9%), Staphylococcus epidermidis (n = 21, 15.3%), Staphylococcus hemolyticus (n = 5, 3.6%), Streptococcus group D (n = 2, 1.5%), Streptococcus pneumoniae (n = 1, 0.7%), and Streptococcus viridans (n = 1, 0.7%). All of the Staphylococci were sensitive to vancomycin; therefore, vancomycin E-test was not performed for these strains. Table 1 shows the results of E-test method for each of tested antibiotics against the isolated microorganisms along with the observed MIC values/ranges at each susceptibility level. None of ciprofloxacin- and vancomycin-resistant isolates in disk diffusion test showed sensitivity in E-test method. Significant differences between the results of disk diffusion and E-test methods were observed for clindamycin and meropenem against S. aureus (p = 0.01 and 0.04, respectively) and Enterococcus spp (p = 0.03 and 0.02, respectively). There were not any significant differences between the disk diffusion and E-test results for other microorganisms.
Table1

Results of E-test method for isolated Gram-positive bacteria resistant/intermediately resistant to antibiotics in disk diffusion test

Antibiotic Microorganism Disk diffusion n E-test
Sensitive n (%) [MIC range] Intermediate n (%) [MIC range] Resistant n (%) [MIC range]
Cephalothin S.aureus Resistant461 (2.2) [6]12 (26.1) [12-24]33 (71.7) [32-256<]
Enterococcus ResistantIntermediate2911 (3.4) [4]03 (10.3) [12-24]1 (100) [16]25 (86.2) [32-256<]0
S.epidermidis ResistantIntermediate611 (16.7) [2]001 (100) [16]5 (83.3) [24-256<]0
S.hemolyticus Resistant31 (33.3) [1]02 (66.7) [256<]
Strep. Group D Resistant1001 (100) [256<]
Oxacillin S.aureus Resistant493 (6.1) [0.12-0.38]046 (93.9) [8-256<]
Enterococcus Resistant301 (3.3) [4]3 (10.0) [6-12]26 (86.7) [48-256<]
S.epidermidis Resistant120012 (100) [2-256<]
S.hemolyticus Resistant3003 (100) [256<]
Strep. Group D Resistant1001 (100) [256<]
S.pneumoniae Resistant1001 (100) [6]
S.viridans Resistant11 (100) [0.5]00
Clindamycin S.aureus Resistant495 (10.2) [0.02-0.64]0 44 (89.8) [24-256<]
Enterococcus Resistant295 (17.2) [0.09-12]024 (82.8) [256<]
S.epidermidis Resistant111 (9.1) [0.02]1 (9.1) [2]9 (81.8) [256<]
S.hemolyticus Resistant3003 (100) [256<]
Strep. Group D Resistant1001 (100) [256<]
S.pneumoniae Resistant1001 (100) [256<]
Ciprofloxacin S.aureus Resistant460046 (100) [5-32]
Enterococcus ResistantIntermediate252001 (4.0) [2]2 (100) [2-3]24 (96.0) [32<]0
S.epidermidis Resistant130013 (100) [4-32<]
S.hemolyticus Resistant3003 (100) [32<]
Strep. Group D Resistant1001 (100) [32<]
Meropenem S.aureus Resistant417 (17.1) [0.12-4]12 (29.3) [5-12]22 (53.7) [16-32<]
Enterococcus ResistantIntermediate2613 (11.5) [1-4]01 (3.8) [8]1 (100) [12]22 (84.6) [32<]0
S.epidermidis Resistant111 (9.1) [4]2 (18.2) [6-12]8 (72.7) [32<]
S.hemolyticus Resistant2002 (100) [32<]
Strep. Group D Resistant1001 (100) [32<]
S.pneumoniae Resistant11 (100) [0.38]00
Vancomycin Enterococcus Resistant160016 (100) [48-256<]
Strep. Group D Resistant1001 (100) [256<]
Teicoplanin Enterococcus Resistant111 (9.1) [4]1 (9.1) [24]9 (81.8) [48-256<]

MIC, minimum inhibitory concentration.

Periodical assessment of common microorganisms’ resistance pattern in the hospitals is essential for the selection of appropriate antibiotic regimen in patients with manifestation of an infection. Proper patient evaluation, collection of suitable patient’s biological sample and coordination with an expert clinical microbiology department help the health care workers accordingly. There are some controversies about the results of methods that were used for the assessment of microorganisms’ antimicrobial susceptibility. Disk diffusion method is the routine laboratory test for microorganisms’ antibiotic susceptibility test in our hospitals. The results of this test are reported as susceptible, intermediate resistant, or resistant. With the development of microbial resistance and change of bacterial sensitivity to antibiotics, it is important to evaluate the MIC for each pathogenic microorganism. Serial dilution or E-test stripes are used for determining MIC. Serial dilution is a precise but time consuming and personnel-dependent method. Our data showed acceptable agreement between the microorganisms’ susceptibility results based on the disk diffusion test and the results of E-test method for cephalothin, oxacillin, ciprofloxacin, vancomycin, and teicoplanin, while there were significant differences between the results of clindamycin and meropenem. In previous studies, different levels of agreement between E-test and disk diffusion in determining antimicrobial sensitivity have been reported, depending on the types of specific organisms and antibiotics used in the studies (7-9). In a recent study performed by Erfani et al., E-test method was carried out for E.coli strains resistant to five antibiotics in disk diffusion test. By E-test method, 47.7% of strains were sensitive to nitrofurantoin, 21.1% sensitive to gentamicin and 10.5% sensitive to cotrimoxazole, ciprofloxacin and ceftazidime (10). Therefore, it seems that the level of agreement for these two methods depends on both antibiotic and microorganism that were tested. Also, the type of applied antibiotic disks may affect the results, as the quality of disks from different manufacturers may not be similar. According to the results of antimicrobial susceptibility testing of S.aureus, S.epidermidis and Enterococcus strains, E-test method is more precise for clindamycin and meropenem. For cephalothin, oxacillin, ciprofloxacin, vancomycin, and teicoplanin, disk diffusion method has the acceptable sensitivity for the detection of resistance pattern of these microorganisms. However, it is better to use E-test method for Stapylococcus and Enterococcus strains that show resistance to either cephalothin or oxacillin disks, since the organisms with reduced (intermediate) susceptibility to these antibiotics may show resistance to disks. Moreover, due to some reports of reduced susceptibility of clinically significant Staphylococci to glycopeptide antimicrobials such as vancomycin (11, 12), vancomycin E-test can be recommended to use if any Staphylococcus strain show resistance to its disk. The same conclusion was made by a study that compared these two methods of vancomycin against the coagulase-negative Staphylococci isolates (CoNS) (13); in this study, four CoNS isolates were resistant to vancomycin by disk diffusion method while showing susceptibility to it by E-test method. This recommendation may also applicable for Enterococcus strains resistant to teicoplanin disk. Results of E-test method for isolated Gram-positive bacteria resistant/intermediately resistant to antibiotics in disk diffusion test MIC, minimum inhibitory concentration.

Conclusions

In order to increase the reliability of antimicrobial susceptibility results, it is recommended to perform E-test for nosocomial Gram-positive microorganisms that show antibiotic resistance via disk diffusion test and it is more important for clindamycin and meropenem.
  8 in total

Review 1.  Antimicrobial resistance: factors and outcomes.

Authors:  Douglas N Fish; Martin J Ohlinger
Journal:  Crit Care Clin       Date:  2006-04       Impact factor: 3.598

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

Review 3.  Antimicrobial resistance in gram-positive bacteria.

Authors:  Louis B Rice
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

4.  Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates.

Authors:  P R Hsueh; J C Chang; L J Teng; P C Yang; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study.

Authors:  E Tacconelli; M Tumbarello; K G Donati; M Bettio; T Spanu; F Leone; L A Sechi; S Zanetti; G Fadda; R Cauda
Journal:  Clin Infect Dis       Date:  2001-10-05       Impact factor: 9.079

6.  Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients.

Authors:  O T Katz; N Peled; P Yagupsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-08       Impact factor: 3.267

7.  Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.

Authors:  Paul P Cook; Paul G Catrou; John D Christie; Pamela D Young; Ronald E Polk
Journal:  J Antimicrob Chemother       Date:  2004-03-24       Impact factor: 5.790

8.  Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.

Authors:  Farid M Hussain; Susan Boyle-Vavra; Priya B Shete; Robert S Daum
Journal:  J Infect Dis       Date:  2002-08-01       Impact factor: 5.226

  8 in total
  5 in total

1.  Elevated Vancomycin Trough Concentration: Increased Efficacy and/or Toxicity?

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Hamid Emadi-Koochak; Amirhooshang Mohammadpour; Alireza Abdollahi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

2.  Atorvastatin for Prevention of Amikacin-induced Electrolytes Imbalances; a Randomized Clinical Trial.

Authors:  Behrooz Heydari; Hossein Khalili; Simin Dashti-Khavidaki; Mohammad Taghi Beig-Mohammadi; Mostafa Mohammadi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

3.  Comparison between Some Phenotypic and Genotypic Methods for Assessment of Antimicrobial Resistance Trend of Bovine Mastitis Staphylococcus aureus Isolates from Bulgaria.

Authors:  Nikolina Rusenova; Nasko Vasilev; Anton Rusenov; Aneliya Milanova; Ivo Sirakov
Journal:  Vet Sci       Date:  2022-07-31

4.  Resistance patterns of Escherichia coli causing urinary tract infection.

Authors:  Elaheh Ferdosi-Shahandashti; Mostafa Javanian; Masoomeh Moradian-Kouchaksaraei; Babak Yeganeh; Ali Bijani; Elahe Motevaseli; Fatemeh Moradian-Kouchaksaraei
Journal:  Caspian J Intern Med       Date:  2015

5.  Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital.

Authors:  Rasool Soltani; Mohsen Ehsanpoor; Farzin Khorvash; Dariush Shokri
Journal:  J Res Pharm Pract       Date:  2014-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.